Sensex Trades Flat, Nifty Around 10,500 Mark; Midcaps Outperform - Dollar Advisory Financial Services

Breaking

Tuesday 26 December 2017

Sensex Trades Flat, Nifty Around 10,500 Mark; Midcaps Outperform

Shares of Alembic Pharmaceuticals rose 1 percent in the early trade on Tuesday as its associate company Rhizen Pharmaceuticals received USFDA approval for cancer drug.

“Rhizen Pharmaceuticals SA announced that USFDA has granted orphan-drug designation for the active moiety of Tenalisib, the company’s highly selective and orally active dual PI3K delta/gamma inhibitor, for the treatment of peripheral T-cell lymphoma,” as per BSE release.

Orphan-drug designation is granted to a drug or biological product intended to treat a rare disease in the United States.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory

No comments:

Post a Comment